COMP <GO>
ACHC vs MRK // NET PROFIT MARGIN
Acadia Healthcare Company Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ACHC 2
— MRK 12
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $29.96 (+1.70%) • MKT CAP: $2.74B
net-margins
-33.30%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACHC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -24.80% | 20.70% | -45.50 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.04% | 3.42% | -19.46 | MRK | /fcf-yield <GO> |
| Operating Margin | -40.60% | 34.30% | -74.90 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -33.30% | 28.10% | -61.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 5.00% | 1.30% | +3.70 | ACHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.19 | -4.74 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.60% | +0.50 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.5 | 56.9 | -6.38 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.92 | +0.15 | ACHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 18.4x | +2.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.74B | $361.02B | -$358.28B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACHC REV | MRK REV | ACHC GROSS % | MRK GROSS % | ACHC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.31B | $65.01B | 44.0% | 74.8% | -$439.9M | $12.36B |
| FY 2024 | $3.15B | $64.17B | 44.0% | 76.3% | -$560.7M | $18.10B |
| FY 2023 | $2.93B | $60.12B | 44.0% | 44.0% | $330.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHC // BETA 1.07
MRK // BETA 0.92